AMENDMENT NO. 1 TO ASSET PURCHASE AGREEMENT WITH BIOTISSUE HOLDINGS INC. DATED JULY 15, 2026
BioStem Technologies, Inc.
Amendment No. 1 to Asset Purchase Agreement
THIS AMENDMENT NO. 1 TO ASSET PURCHASE AGREEMENT (this “Amendment”), dated as of July 15, 2026, is by and among (a) BLUE TECH INDUSTRIES, INC., a Delaware corporation (the “Purchaser”); (b) BIOSTEM TECHNOLOGIES, INC., a Delaware corporation (“Parent”) (solely for the purposes of Section 7.14 of the Agreement); (c) BIOTISSUE HOLDINGS INC., a Florida corporation (“BT Holdings”); and (d) BIOTISSUE SURGICAL INC., a Delaware corporation (“BT Surgical”, together with BT Holdings, the “Sellers” and each, a “Seller”). The Purchaser and the Sellers are sometimes individually referred to herein as a “Party” and collectively as the “Parties.” Capitalized terms used but not defined herein will have the meanings ascribed to them in the Agreement (as defined below).
BACKGROUND
A. The Parties are parties to that certain Asset Purchase Agreement dated as of January 21, 2026 (the “Agreement”).
…